Bemarituzumab (Anti-FGFR2 / CD332)
Product Specifications
CAS Number
1952272-74-0
Target
FGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134730-ML650 100 µL
TRIM24 (Transcription Intermediary Factor 1-alpha, TIF1-alpha, E3 Ubiquitin-protein Ligase TRIM24, RING Finger Protein 82, Tripartite Motif-containing Protein 24, RNF82, TIF1, TIF1A) (MaxLight 650)
Sign In for Pricing
View Details 
GTR10349775 96 Well
Sheep Triosephosphate isomerase (TPI1) ELISA Kit
Sign In for Pricing
View Details MBS6279291-01 0.1 mL
BTNL3, CT (BTNL3, BTNLR, COLF4100, Butyrophilin-like protein 3, Butyrophilin-like receptor) (MaxLight 405)
Sign In for Pricing
View Details